此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Bedside Evaluation of Coagulation in Children With Congenital Heart Disease (POCHEMO)

2018年1月24日 更新者:David Longchamp、Centre Hospitalier Universitaire Vaudois

"Point-Of-Care" Evaluation of Hemostasis in Children With Congenital Heart Disease

The purpose of this study is to assess coagulation and platelet function in children with congenital heart disease, measured with a bedside device (thromboelastometry and impedance aggregometry).

The investigators also aim to determine if this device detect post-cardiopulmonary bypass clotting derangements and may help to manage bleeding in this population.

研究概览

地位

完全的

详细说明

Hemostasis, a main concern during and after any surgical procedure, is traditionally monitored by the following laboratory tests: activated Partial Thrombin Time (aPTT), prothrombin time (PT), fibrinogen, platelets count. They neither provide a reliable estimate of the risk of bleeding, nor allow determining useful interventions.

New investigations of hemostasis are now used and validated during and after surgery: Rotational Thromboelastometry (ROTEM®) and impedance aggregometry. This is a quick bedside functional analysis of the patient's clotting. Children who undergo surgery under cardiopulmonary bypass (CPB) are particularly at risk of bleeding and this population hasn't been studied with large cohort yet.

Hypothesis: Hemostasis in children with CHD, especially when cyanotic, is intrinsically abnormal. The corrective surgery on CPB induces further hemostatic disorders which can be identified by the ROTEM platelet®.

The aim of the study is to evaluate the hemostatic function of the child with congenital heart disease using a Point-Of-Care (platelet-ROTEM ®) system, before surgery and after alterations induced by cardiopulmonary bypass (CPB).

This is a single center, observational, prospective study. Expected duration: 2 years. The investigators plan to include 200 patients with CHD, 100 patients undergoing surgery with CPB and 100 patients with congenital heart disease requiring cardiac catheterization. Recruitment will be conducted by the Division of Paediatric Cardiology.

Inclusion criteria include an age of 0-16 years and a diagnosis of congenital heart disease requiring surgery with CPB or cardiac catheterization. Patients with known dyscrasia or treated with antiaggregant within 10 days/oral anticoagulants within 48h before surgery/catheterization.

ROTEM platelet® test will be performed before surgery/catheterization. Patients undergoing surgery will have a second test within 30 minutes after the end of cardiopulmonary bypass. All patients will benefit from the usual cares.

研究类型

观察性的

注册 (实际的)

200

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Vaud
      • Lausanne、Vaud、瑞士、1011
        • PICU, Centre Hospitalier Universitaire Vaudois

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

不超过 16年 (孩子)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

概率样本

研究人群

Children with congenital heart defect

描述

Inclusion Criteria:

  • children between 0 and 16 years, born with a congenital heart disease requiring either cardiac catheterization or surgery with cardiopulmonary bypass
  • parental and/or patient consent

Exclusion Criteria:

  • known hemostatic disorder
  • known platelet function disorder
  • antiaggregation treatment <10 days before blood sampling
  • oral anticoagulation <2 days before blood sampling
  • intravenous heparin <6 hours before blood sampling
  • patient and parents unable to consent

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
Cardiopulmonary bypass
Children with congenital heart defect undergoing surgery on cardiopulmonary bypass
cardiac catheterism
Children with congenital heart defect undergoing cardiac catheterism

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Hemostasis measured by thromboelastometry and impedance aggregometry
大体时间:Single measurement, during general anesthesia, immediately before procedure, when arterial line available
Single measurement, during general anesthesia, immediately before procedure, when arterial line available
Hemostasis measured by thromboelastometry and impedance aggregometry in cyanotic children
大体时间:Single measurement, during general anesthesia, immediately before procedure, when arterial line available
Single measurement, during general anesthesia, immediately before procedure, when arterial line available

次要结果测量

结果测量
大体时间
Thromboelastometry and impedance aggregometry changes after cardiopulmonary bypass (CPB)
大体时间:maximum 3 measurements, during surgery and up to 6 hours after end of CBP
maximum 3 measurements, during surgery and up to 6 hours after end of CBP
Thromboelastometry and impedance aggregometry changes in children with significant bleeding after CPB
大体时间:Single measurement, during general anesthesia, immediately before procedure, when arterial line available
Single measurement, during general anesthesia, immediately before procedure, when arterial line available

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Stefano Di Bernardo, MD、CHUV

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2015年3月1日

初级完成 (实际的)

2017年7月6日

研究完成 (实际的)

2017年7月7日

研究注册日期

首次提交

2015年3月5日

首先提交符合 QC 标准的

2015年3月12日

首次发布 (估计)

2015年3月13日

研究记录更新

最后更新发布 (实际的)

2018年1月26日

上次提交的符合 QC 标准的更新

2018年1月24日

最后验证

2018年1月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅